HIMS Insider Filing: Dudum Exercises $2.43 Options and Sells Multiple Blocks
Rhea-AI Filing Summary
Andrew Dudum, Director and CEO of Hims & Hers Health, Inc. (HIMS), reported multiple transactions on 08/18/2025 conducted under a Rule 10b5-1 plan. The filing shows option exercises at an exercise price of $2.43 for 17,001 and 108,334 options, and subsequent sales of shares from those exercises and existing holdings at average weighted prices in the mid-$44 to mid-$45 range. Reported sales on that date include blocks of 47,534; 2,792; 17,001; 41,667; 50,000; and 16,667 shares at various average prices around $44.76–$45.42. Post-transaction beneficial ownership across direct and indirect holdings is reported for numerous trusts, with notable indirect positions such as 1,016,871 and 2,214,769 shares held by trustees. The Form 4 is signed by an attorney-in-fact on 08/20/2025.
Positive
- Transactions executed under a Rule 10b5-1 trading plan, providing an affirmative defense and predictable execution timing.
- High disclosure quality: filing details option exercise prices, weighted average sale prices, and indirect holdings by trust.
- Significant indirect holdings remain across multiple trusts, indicating continued economic interest in the company.
Negative
- Material insider sales on 08/18/2025 (multiple blocks sold at ~$45), which reduce the reporting person’s direct holdings.
- Direct holdings decreased through multiple disposals, potentially reducing direct voting exposure despite retained indirect positions.
Insights
TL;DR: Insider exercised low-cost options and sold substantial shares under a pre-existing 10b5-1 plan, realizing proceeds at ~45x exercise price.
The reporting shows exercises of options with a $2.43 strike and immediate or near-immediate sales at weighted average prices ~$45, indicating monetization of long-held equity rather than opportunistic market-timing because trades were executed under a Rule 10b5-1 plan. The volumes sold (multiple blocks totaling >150,000 shares on listed line items) reduce the reporting person’s direct holdings while large indirect trust positions remain material. For investors, this is a liquidity event by an insider but not necessarily a signal of company fundamentals given the 10b5-1 context.
TL;DR: Transactions follow a documented trading plan, demonstrating governance compliance while materially altering direct ownership.
The filing discloses that the transactions were effected under a 10b5-1 plan adopted 08/28/2024, which supports compliance with insider-trading rules. Multiple transfers among trusts and annuity-in-kind movements are disclosed, showing estate and wealth-planning activity. While disclosure quality is high, the scale of sales and the retention of large indirect stakes via trusts underscore continued economic alignment but reduced direct voting exposure. The activity is governance-relevant but not a regulatory concern based on the information provided.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 17,001 | $0.00 | -- |
| Exercise | Stock Option (right to buy) | 108,334 | $0.00 | -- |
| Sale | Class A Common Stock | 47,534 | $45.0518 | $2.14M |
| Sale | Class A Common Stock | 2,792 | $44.965 | $126K |
| Exercise | Class A Common Stock | 17,001 | $2.43 | $41K |
| Sale | Class A Common Stock | 17,001 | $45.1373 | $767K |
| Exercise | Class A Common Stock | 108,334 | $2.43 | $263K |
| Sale | Class A Common Stock | 41,667 | $45.1111 | $1.88M |
| Sale | Class A Common Stock | 50,000 | $45.0396 | $2.25M |
| Sale | Class A Common Stock | 16,667 | $44.9209 | $749K |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.76 - $45.42. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.85 - $45.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.95 - $45.39. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.68 - $45.43. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.69 - $45.40. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $44.65 - $45.35. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This amount reflects an annuity payment-in-kind of 26,461 shares of Class A Common Stock to the Andrew Dudum 2015 Trust dated July 2, 2015 from the AD 2022 GRAT. This amount reflects an annuity payment-in-kind of 26,461 shares of Class A Common Stock from the AD 2022 GRAT to the Andrew Dudum 2015 Trust dated July 2, 2015. Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021. The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.
